https://doi.org/10.31288/oftalmolzh201836367

Ecological causality of the central serous chorioretinopathy incidence in the Sumy region

Kuzenko O.V.1, a Postgraduate Student; Dyomin Yu.A.1, Dr Med Sc, Prof.; Litvinova L.V.1, Cand. Med. Sc.; Kuzenko E.V.2, Cand. Med. Sc.

1 Kharkiv Medical Academy of Postgraduate Education; Kharkiv (Ukraine)

2 Sumy State University; Sumy (Ukraine)

E-mail: logvinenok26@gmail.com                    

TO CITE THIS ARTICLE: Kuzenko OV, Dyomin YuA, Litvinova LV, Kuzenko EV. Ecological causality of the central serous chorioretinopathy incidence in the Sumy region.  J.ophthalmol.(Ukraine).2018;3:63-67. https://doi.org/10.31288/oftalmolzh201836367

      

Background. Studying anthropoecological factors is required to specify risk factors and predictors of central serous chorioretinopathy (CSCR).

Purpose. To analyze a level of atmospheric air pollution by Cr6+ and to assess its influence on the incidence of central serous chorioretinopathy among adult population of the Sumy region.

Material and Methods. Data on registration of patients for CSCR treatment (according to ICD-10: Н35.7) from 2005 to 2017 were analyzed. The data were obtained in Statistical Department of Sumy Regional Clinical Hospital. Official information data on air pollution by Cr6+ emission at PJSC Sumy NPO were studied.

Results. For the entire period of observation, the CSCR incidence in the Sumy region shows a clear tendency to increase. The correlation analysis confirmed the fact that CSCR is determined by Cr6+ emission in the atmospheric air and showed a direct (correlation coefficient r = 0.85) significant (p = 0.0007) relationship (Fig. 3) between the CSCR incidence rate and the levels of Cr6+ emission in the atmosphere.

Conclusion. Cr6+ was found to have an indirect and induced effect on the CSCR incidence  in the Sumy region.

Key-words: central serous chorioretinopathy, chrome, ecological factor, correlation analysis

References

1.Moschos M, Brouzas D, Koutsandrea C. Assessment of central serous chorioretinopathy by opnical coherence tomography and multifocal electroretinography. Ophtalmologica. 2007; 221 (5): 292-298.
Crossref   Pubmed

2.Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003 Apr;110(4):698-703.
Crossref   Pubmed

3.Kleinberger AJ, Patel C, Lieberman RM, Malkin BD. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature. Laryngoscope. 2011 Sep;121(9):2034-7.

4.Stoffelns BM, Kramann C, Schoepfer K. [Central serous chorioretinopathy (CSC) and corticosteroids]. Klin Monbl Augenheilkd. 2008 May;225(5):370-5.
Crossref   Pubmed

5.Pastor-Idoate S, Peña D, Herreras JM. Adrenocortical adenoma and central serous chorioretinopathy: a rare association?. Case Rep Ophthalmol. 2011 Sep;2(3):327-32.
Crossref   Pubmed

6.Giovansili I, Belange G, Affortit A. Cushing disease revealed by bilateral atypical central serous chorioretinopathy: case report.. Endocr Pract. 2013 Sep-Oct;19(5):129-33.
Crossref   Pubmed

7.Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study. Curr Eye Res. 2017 Jul;42(7):1069-1073.
Crossref   Pubmed

8.Maggio E, Polito A, Freno MC, Pertile G. Multimodal imaging findings in a case of severe Central Serous Chorioretinopathy in an uncomplicated pregnancy. BMC Ophthalmol. 2015 Dec 22;15:183.
Crossref   Pubmed

9.Zavoloka O, Bezditko P, Lahorzhevska I, Zubkova D, Ilyina Y. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1737-42.
Crossref   Pubmed

10.Mateo-Montoya A, Mauget-Faÿse M. Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review. World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):355-358.
Crossref   Pubmed

11.Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: A Systematic Review and Meta-Analysis. Retina. 2016 Jan;36(1):9-19.
Crossref   Pubmed

12.Balkarli A, Erol MK, Yucel O, Akar Y. Frequency of fibromyalgia syndrome in patients with central serous chorioretinopathy. Arq Bras Oftalmol. 2017 Jan-Feb;80(1):4-8.
Crossref   Pubmed

13.Witmer MT, Klufas MA, Kiss S. Polycystic Ovary Syndrome and Central Serous Chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):684-686.
Crossref   Pubmed

14.Voitiuk Yu Yu, Kuraieva IV, Kroik HA, Matsibora OV, Matviienko OV. [Patterns of the distribution of heavy metals in the objects of the city of Sumy]. Visnyk Dnipropetrovskoho universytetu. Seriia: heolohiia, heohrafiia. 2016; 24(2):18–24. In Ukrainian.

15.Melnyk OS. [Utilization of wastewaters of galvanic production and their neutralization]: avtoref. dys. na zdobuttia nauk. stupenia kand. tekhn. nauk. 2011: 20. In Ukrainian.

16.[Integrated Waste Management Program in Sumy Oblast for 2016-2020]. [Internet]. Available from: http://www.gkh.sm.gov.ua/index.php/uk/833-kompleksna-programa-povodzhenn.... In Ukrainian.

17.Skorokhod AV. [Medico-social substantiation of the model of voluntary medical insurance in the system of budget insurance medicine (for example, Sumy region): avtoref. dys. kand. med. nauk]: 14.02.03. Kyiv. 2015; 28. In Ukrainian.

18.Jay ER, John MD. Heavy Metal Concentration in Human Eyes. American Journal of Ophthalmology. 2005; 139(5): 888-894.
Crossref   Pubmed

19.Ng SK, Ebneter A, Gilhotra JS. Hip-implant related chorio-retinal cobalt toxicity. Indian J. Ophthalmol. 2013; 61(1): 35 – 37. 
Crossref   Pubmed

20.Benedyktova OA, Riukov SA, Suk SA, Saksonov SH. [Central serous chorioretinopathy. New look at etiology and pathogenesis (review of literature)]. Ukrainskyi naukovo-medychnyi molodizhnyi zhurnal. 2013; 1: 49-52. In Russian.